πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 710 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7825216

Phenylanine derivatives

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7825096

O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrug

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7825159

Mixtures of aromatic esters for marking or tagging organic products, marker compositions c

UNITED COLOR MANUFACTURING, INC. Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7790433

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer usi

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7786290

Double-stranded ribonucleic acid with increased effectiveness in an organism

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7767303

Cleaning article containing hydrophilic polymers

ReGenesis Group Β· Granted Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7763719

Variants of humanized anti-carcinoma MAb CC49

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7759313

Induction method for cell differentiation

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU β€œPHARMENTERPRISES” Β· Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7704558

Cleaning article containing hydrophilic polymers

ReGenesis Group Β· Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638678

Animal model for perimenopause and menopause and methods of inducing ovarian failure

THE ARIZONA BOARD OF REGENTS Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7629323

Manipulation of neuronal ion channels

Northwestern University Β· Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622467

Aryl aniline derivatives as Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7611693

Mechanism-based targeted pancreatic beta cell imaging and therapy

The Board of Regents of the University of Texas System Β· Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7608272

Methods and compositions for vaccination of animals with PRRSV antigens with improved immu

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7604968

Microorganisms for the recombinant production of resveratrol and other flavonoids

Regents of the University of Minnesota Β· Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7604811

Oral-intestinal vaccines against diseases caused by enteropathic organisms using antigens

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7589181

Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582765

Aryl aniline Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7569673

Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566785

Amidine substituted aryl aniline compounds

Theravance, Inc. Β· Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566552

Protection against environmental toxicity through manipulation of the processing of messen

CropDesign N.V. Β· Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566732

Rhodanine compositions for use as antiviral agents

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560263

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer usi

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7553653

Variants and chemically-modified variants of phenylalanine ammonia-lyase

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted